Estimate Recalculated Sep 18, 2024 12:59AM EST
M Kathleen Behrens has an estimated net worth of $22.8 Million. This is based on reported shares across multiple companies, which include MIMEDX GROUP, INC., Sarepta Therapeutics, Inc., IGM Biosciences, Inc., AMYLIN PHARMACEUTICALS INC, and ABGENIX INC.
M Kathleen Behrens's CIK is 0001211701
2020 was M Kathleen Behrens's most active year for acquiring shares with 18 total transactions. M Kathleen Behrens's most active month to acquire stocks was the month of February. 2006 was M Kathleen Behrens's most active year for disposing of shares, totalling 7 transactions. M Kathleen Behrens's most active month to dispose stocks was the month of March. 2016 saw M Kathleen Behrens paying a total of $1,075,275.50 for 76,500 shares, this is the most they've acquired in one year. In 2006 M Kathleen Behrens cashed out on 310,115 shares for a total of $2,252,587.50, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!